Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in February.

With April 29 being Day 100 for U.S. President Donald Trump, his staff observed the day by touting the achievements of the administration’s first 100 days in office, especially new commitments made by ...

But those efforts have been costly. Starbucks said its net income dropped 50% to $384 million in its fiscal second quarter. Adjusted earnings fell nearly 40% to 41 cents per share. That was lower than ...

Recent health news highlights include Sandoz's criticism of EU drug pricing, a US-Mexico pact on pest control, advancements in cancer therapies, and significant corporate deals. Studies, policy ...

ARLINGTON, Va. (AP) — ARLINGTON, Va. (AP) — CoStar Group Inc. (CSGP) on Tuesday reported a loss of $14.8 million in its first quarter. On a per-share basis, the Arlington, Virginia-based company said ...

WESTFORD, Mass. (AP) — WESTFORD, Mass. (AP) — Kadant Inc. (KAI) on Tuesday reported first-quarter profit of $24.1 million. The Westford, Massachusetts-based company said it had net income of $2.04 per ...

American Assets Trust expects full-year funds from operations to be $1.87 to $2.01 per share. The company's shares have declined 29% since the beginning of the year. In the final minutes of trading on ...

NELSONVILLE, Ohio (AP) — NELSONVILLE, Ohio (AP) — Rocky Brands Inc. (RCKY) on Tuesday reported earnings of $4.9 million in its first quarter. The Nelsonville, Ohio-based company said it had net income ...

Blue Heron Farm, in the town of Chilmark in Martha’s Vineyard, Massachusetts was used by the Obama family for three summers ...

Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Sullivan & Cromwell is acting for longtime client Merck in its $3.9bn acquisition of US biotech company SpringWorks Therapeutics, which is being repped by Goodwin Procter.